Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2

Cell Mol Immunol. 2022 Sep;19(9):1067-1069. doi: 10.1038/s41423-022-00870-5. Epub 2022 May 17.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Binding Sites
  • COVID-19*
  • Humans
  • Mutation
  • Protein Binding
  • SARS-CoV-2*
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / metabolism

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2

Supplementary concepts

  • SARS-CoV-2 variants